Mergers & acquisitions

February 8, 2013, 7:43 PM UTC

Alere Inc. (NYSE: ALR) has acquired Epocal Inc., an Ottawa–based provider of technologies that support blood gas and electrolyte testing at the point of care. The deal is valued at upwards of $241.5 million, including a $166 million up-front cash payment. Epocal had raised over $30 million in VC funding from firms like Highland Capital Management, Genesys Capital Partners, MM Venture Partners, New Generation Biotech and Covington Capital. (NYSE: CRM) has acquired EntropySoft, a Paris-based content connection software startup. No financial terms were disclosed. EntropySoft had been seeded by Alven Capital.

Curtiss-Wright Corp. (NYSE: CW) has acquired Exlar Corp., a Chanhassen, Minn.–based maker of actuators used in motion control solutions for the industrial and military markets. The deal was valued at $85 million in cash, with Greene Holcomb & Fisher managing the process.

Decade Sunshine Ltd. has agreed to acquire 3SBio Inc. (NASDAQ: SSRX), a Chinese biotech company, for around $350 million, or $15.40 per share. The company previously had received a $15 per share offer from CITIC Private Equity and 3SBio chairman and CEO Jing Lou.

FolioDynamix Corp
., a New York-based provider of fee-based managed account solutions for the wealth management industry, has acquired Access Partners, a registered investment advisor focused on trust investment management and operations. No pricing terms of the all-cash transaction were disclosed. FolioDynamics has raised over $24 million in VC funding from ABS Capital Partners, Edison Ventures, Cambrian and Velocity Financial Group.

Tranzyme (Nasdaq: TZYM) said that it has hired Stifel to explore strategic alternatives, including a possible sale of the company. The Durham, N.C.-based company went public less than two years ago, but recently stopped late-stage clinical trials on a new treatment for stomach paralysis due to lack of efficacy. The company’s market cap is around $15 million.

Sign up for my daily email newsletter on deals and deal-makers: